Bank of Nova Scotia’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5M Sell
1,323,635
-979,376
-43% -$53.2M 0.09% 180
2026
Q1
$145M Buy
2,303,011
+308,930
+15% +$24.7M 0.25% 71
2025
Q4
$190M Sell
1,994,081
-680,471
-25% -$66.7M 0.28% 60
2025
Q3
$261M Sell
2,674,552
-350,967
-12% -$36.3M 0.46% 34
2025
Q2
$325M Buy
3,025,519
+1,559,605
+106% +$158M 0.67% 24
2025
Q1
$148M Buy
1,465,914
+1,080,937
+281% +$109M 0.33% 51
2024
Q4
$34.4M Buy
384,977
+50,654
+15% +$4.46M 0.06% 217
2024
Q3
$28M Buy
334,323
+141,589
+73% +$11.2M 0.06% 193
2024
Q2
$14.8M Sell
192,734
-36,314
-16% -$2.66M 0.03% 307
2024
Q1
$15.7M Sell
229,048
-292,408
-56% -$18.8M 0.03% 317
2023
Q4
$30.1M Buy
521,456
+324,446
+165% +$17.3M 0.06% 232
2023
Q3
$10.4M Sell
197,010
-23,326
-11% -$1.22M 0.03% 311
2023
Q2
$11.9M Sell
220,336
-78,324
-26% -$4.09M 0.03% 261
2023
Q1
$14.9M Buy
298,660
+47,701
+19% +$2.25M 0.04% 228
2022
Q4
$11.6M Buy
250,959
+468
+0.2% +$20.3K 0.03% 325
2022
Q3
$9.7M Sell
250,491
-2,473
-1% -$99.2K 0.03% 312
2022
Q2
$9.44M Sell
252,964
-59,122
-19% -$2.41M 0.02% 379
2022
Q1
$13.8M Sell
312,086
-83,887
-21% -$3.64M 0.02% 385
2021
Q4
$16.8M Buy
395,973
+79,992
+25% +$3.36M 0.02% 416
2021
Q3
$13.7M Buy
315,981
+117,380
+59% +$5.19M 0.02% 422
2021
Q2
$8.49M Sell
198,601
-72,192
-27% -$3.04M 0.02% 482
2021
Q1
$10.5M Buy
270,793
+29,572
+12% +$1.12M 0.02% 394
2020
Q4
$8.67M Buy
241,221
+61,628
+34% +$2.22M 0.02% 403
2020
Q3
$6.86M Sell
179,593
-342,910
-66% -$13.2M 0.02% 415
2020
Q2
$18.3M Sell
522,503
-165,365
-24% -$5.96M 0.06% 222
2020
Q1
$22.4M Buy
687,868
+259,418
+61% +$10.1M 0.08% 205
2019
Q4
$19.4M Buy
428,450
+309,005
+259% +$12.9M 0.05% 284
2019
Q3
$4.86M Sell
119,445
-386,296
-76% -$16.4M 0.01% 499
2019
Q2
$21.5M Sell
505,741
-54,455
-10% -$2.09M 0.09% 208
2019
Q1
$21.5M Buy
560,196
+128,420
+30% +$4.9M 0.09% 224
2018
Q4
$15.3M Sell
431,776
-206,619
-32% -$7.49M 0.07% 214
2018
Q3
$24.6M Buy
638,395
+266,412
+72% +$9.3M 0.11% 172
2018
Q2
$12.2M Buy
371,983
+197,014
+113% +$5.94M 0.07% 225
2018
Q1
$4.78M Sell
174,969
-464,457
-73% -$12.6M 0.02% 395
2017
Q4
$15.9M Buy
639,426
+401,077
+168% +$11.1M 0.07% 240
2017
Q3
$6.95M Sell
238,349
-70,414
-23% -$1.94M 0.04% 312
2017
Q2
$8.56M Sell
308,763
-2,990
-1% -$79.4K 0.04% 317
2017
Q1
$7.75M Buy
311,753
+281,345
+925% +$6.84M 0.03% 327
2016
Q4
$658K Buy
30,408
+2,832
+10% +$61.8K ﹤0.01% 555
2016
Q3
$656K Buy
27,576
+650
+2% +$15.5K ﹤0.01% 468
2016
Q2
$629K Buy
26,926
+1,660
+7% +$35.9K ﹤0.01% 456
2016
Q1
$475K Buy
25,266
+420
+2% +$7.38K ﹤0.01% 482
2015
Q4
$458K Buy
24,846
+30
+0.1% +$538 ﹤0.01% 525
2015
Q3
$407K Buy
24,816
+1,140
+5% +$19.5K ﹤0.01% 471
2015
Q2
$419K Buy
23,676
+1,000
+4% +$17.9K ﹤0.01% 397
2015
Q1
$402K Sell
22,676
-10,706
-32% -$169K ﹤0.01% 408
2014
Q4
$443K Hold
33,382
﹤0.01% 386
2014
Q3
$394K Buy
33,382
+2,415
+8% +$30.4K ﹤0.01% 403
2014
Q2
$395K Buy
30,967
+508
+2% +$6.61K ﹤0.01% 394
2014
Q1
$412K Sell
30,459
-21,133
-41% -$277K ﹤0.01% 413
2013
Q4
$621K Buy
51,592
+409
+0.8% +$4.83K ﹤0.01% 361
2013
Q3
$601K Buy
51,183
+315
+0.6% +$3.41K ﹤0.01% 324
2013
Q2
$472K Buy
+50,868
New +$431K ﹤0.01% 322

Other funds holding BSX

Bank of Nova Scotia's BSX Position: Q2 2026 in Review

Bank of Nova Scotia reduced its Boston Scientific (BSX) stake by 43% in Q2 2026, selling an estimated $53.2M and leaving 1,323,635 shares worth $56.5M. The position accounts for 0.09% of the portfolio, ranked #180.

Bank of Nova Scotia first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $325M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bank of Nova Scotia held 1,323,635 shares of Boston Scientific worth $56.5M as of Q2 2026.
  • Bank of Nova Scotia sold 979,376 Boston Scientific shares in Q2 2026, an estimated $53.2M.
  • Boston Scientific made up 0.09% of Bank of Nova Scotia's portfolio in Q2 2026, its #180 holding.
  • Bank of Nova Scotia first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Bank of Nova Scotia's Boston Scientific position peaked at $325M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.